HIH News

Progressive Supranuclear Palsy: New gene therapy launched

A current study is investigating the tolerability and efficacy of a novel therapeutic technique for treating Progressive Supranuclear Palsy (PSP) at the Center of Neurology. To slow the progression of the disease, a short piece of nucleic acid is administered into the cerebrospinal fluid. New study participants may be included.

Read our press release (in German only)

The first Tübingen patient surrounded by the treatment team: Prof. Thomas Gasser, Dr. Benjamin Röben, Dr. Isabel Wurster, Gabriela Ragusa, Tanja Heger, patient Hans-Jürgen Maurer, his wife Brigitte Maurer, PD Dr. Kathrin Brockmann, Franca Fries and Susanne Solbrig.

Copyright: Thomas Müller / Universitätsklinikum Tübingen